[Would prescription of erythropoiesis-stimulating agents in pre-dialysis change after results from TREAT study?]

Nefrologia. 2010;30(1):114-8. doi: 10.3265/Nefrologia.pre2009.Dic.5903. Epub 2009 Dec 14.
[Article in Spanish]
No abstract available

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Anemia / complications*
  • Anemia / drug therapy*
  • Chronic Disease
  • Darbepoetin alfa
  • Double-Blind Method
  • Erythropoietin / analogs & derivatives*
  • Erythropoietin / therapeutic use
  • Female
  • Follow-Up Studies
  • Hematinics / therapeutic use*
  • Humans
  • Kidney Diseases / complications*
  • Male
  • Renal Dialysis*

Substances

  • Hematinics
  • Erythropoietin
  • Darbepoetin alfa